Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
about
Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsDexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behaviorPulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation?Imaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease.Protective effect and localization by optical imaging of human renal CD133+ progenitor cells in an acute kidney injury modelThe potential role of stem cells in the treatment of urinary incontinence.Maximum efficacy of mesenchymal stem cells in rat model of renal ischemia-reperfusion injury: renal artery administration with optimal numbersIn Vivo Bioluminescence Imaging - A Suitable Method to Track Mesenchymal Stromal Cells in a Skeletal Muscle Trauma.In Vivo Tracking of Systemically Administered Allogeneic Bone Marrow Mesenchymal Stem Cells in Normal Rats through Bioluminescence Imaging.The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injuryConcise review: mesenchymal stem cell treatment for ischemic kidney diseaseConcise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives.Therapeutic use of human renal progenitor cells for kidney regeneration.Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating HIF and ROS hypoxic signalings.Renal Ischemia-Reperfusion Injury in a Diabetic Monkey Model and Therapeutic Testing of Human Bone Marrow-Derived Mesenchymal Stem Cells
P2860
Q27026350-846F6681-7EFE-4E22-8198-9AA4F5434905Q27311400-986A1DED-46FE-4D61-9723-91336C8710F7Q27329535-CB9D8D0C-5DBE-4A3B-806A-7A975E90A446Q28069954-DE15C111-9F61-43DA-BA37-E76806935D67Q30370543-6F721A10-48BE-415F-9800-F81F0FE23784Q33902872-73B8A42F-BA23-4E1D-80CF-9EA2BBD8AAF8Q34961830-FDCCF923-4395-4BFF-8E6B-8209629DE4C4Q35122939-4DEC3175-9AC3-4669-BC7B-14DD64E59F20Q35969879-8C9CB770-2435-4E14-BE01-A3F747B1532CQ37218759-E8E22865-2FFA-4D5B-AC50-951CDE141A76Q37631034-DFC40C5D-60CE-4137-B26F-C98E1B486ED8Q38114399-079B3F2F-06F3-4C4C-BB09-133C972DB33EQ38156153-DFF9FD94-83F0-4915-8882-2D34E5D18D7DQ38560470-7415B131-BD44-4CB6-BC00-0FEF8C47F76EQ46255829-FDAE1BDD-2C22-4DB1-A0DB-B808DED3B9B7Q58805856-A6EF2BBD-9998-4593-81E7-621242CBB703
P2860
Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Efficiency of endovenous versu ...... ced renal dysfunction in rats.
@en
Efficiency of endovenous versu ...... ced renal dysfunction in rats.
@nl
type
label
Efficiency of endovenous versu ...... ced renal dysfunction in rats.
@en
Efficiency of endovenous versu ...... ced renal dysfunction in rats.
@nl
prefLabel
Efficiency of endovenous versu ...... ced renal dysfunction in rats.
@en
Efficiency of endovenous versu ...... ced renal dysfunction in rats.
@nl
P2093
P1476
Efficiency of endovenous versu ...... ced renal dysfunction in rats.
@en
P2093
P304
P356
10.1016/J.TRANSPROCEED.2012.07.162
P407
P577
2013-03-01T00:00:00Z